Stock Track | Amphastar Pharmaceuticals Plunges 6.87% Post-Market on Q4 Earnings and Revenue Miss

Stock Track02-27

Amphastar Pharmaceuticals' stock experienced a significant 24-hour plunge of 6.87% during post-market trading on Thursday.

The sharp decline followed the company's release of fourth-quarter financial results that fell short of analyst expectations. Amphastar reported adjusted earnings per share of $0.73, missing the consensus estimate of $0.92 by 20.82%. Revenue also disappointed at $183.105 million, coming in 3.87% below the $190.480 million estimate.

The results represented a year-over-year decline in both metrics, with earnings decreasing 20.65% and revenue dropping 1.83% compared to the same period last year. The across-the-board misses in key financial indicators prompted the sell-off as investors reacted to the weaker-than-expected performance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1126253863?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-27 10:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126253863","market":"nz","top_or_hot":-1,"title":"Stock Track | Amphastar Pharmaceuticals Plunges 6.87% Post-Market on Q4 Earnings and Revenue Miss","media":"Stock Track","content":"<p>Amphastar Pharmaceuticals' stock experienced a significant 24-hour plunge of 6.87% during post-market trading on Thursday.</p><p>The sharp decline followed the company's release of fourth-quarter financial results that fell short of analyst expectations. Amphastar reported adjusted earnings per share of $0.73, missing the consensus estimate of $0.92 by 20.82%. Revenue also disappointed at $183.105 million, coming in 3.87% below the $190.480 million estimate.</p><p>The results represented a year-over-year decline in both metrics, with earnings decreasing 20.65% and revenue dropping 1.83% compared to the same period last year. The across-the-board misses in key financial indicators prompted the sell-off as investors reacted to the weaker-than-expected performance.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Amphastar Pharmaceuticals Plunges 6.87% Post-Market on Q4 Earnings and Revenue Miss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Amphastar Pharmaceuticals Plunges 6.87% Post-Market on Q4 Earnings and Revenue Miss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-27 10:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Amphastar Pharmaceuticals' stock experienced a significant 24-hour plunge of 6.87% during post-market trading on Thursday.</p><p>The sharp decline followed the company's release of fourth-quarter financial results that fell short of analyst expectations. Amphastar reported adjusted earnings per share of $0.73, missing the consensus estimate of $0.92 by 20.82%. Revenue also disappointed at $183.105 million, coming in 3.87% below the $190.480 million estimate.</p><p>The results represented a year-over-year decline in both metrics, with earnings decreasing 20.65% and revenue dropping 1.83% compared to the same period last year. The across-the-board misses in key financial indicators prompted the sell-off as investors reacted to the weaker-than-expected performance.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AMPH","symbol_name":"Amphastar Pharmaceuticals","start_time":0,"source_url":"","article_id":"1126253863","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126253863","pubTimestamp":1772160960,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Amphastar Pharmaceuticals' stock experienced a significant 24-hour plunge of 6.87% during post-market trading on Thursday.The sharp decline followed the company's release of fourth-quarter financial...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AMPH":"Amphastar Pharmaceuticals"},"translate_title":"个股追踪|Amphastar Pharmaceuticals盘后暴跌6.87%因Q4盈利和营收未达预期","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMPH":1},"content_text":"Amphastar Pharmaceuticals' stock experienced a significant 24-hour plunge of 6.87% during post-market trading on Thursday.The sharp decline followed the company's release of fourth-quarter financial results that fell short of analyst expectations. Amphastar reported adjusted earnings per share of $0.73, missing the consensus estimate of $0.92 by 20.82%. Revenue also disappointed at $183.105 million, coming in 3.87% below the $190.480 million estimate.The results represented a year-over-year decline in both metrics, with earnings decreasing 20.65% and revenue dropping 1.83% compared to the same period last year. The across-the-board misses in key financial indicators prompted the sell-off as investors reacted to the weaker-than-expected performance.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1126253863","isCrawlerRequest":true}